
0:00
22:02
If AI contributes to device design, development, or lifecycle decision-making, who is responsible for safety? In this episode, Ravi Nabar, CEO of QuAIZen, explores how manufacturers can govern AI-assisted innovation through validation, documentation, quality-system controls, post-market monitoring, and evolving regulatory expectations.
Weitere Episoden von „Medical Design Briefs Podcast“



Verpasse keine Episode von “Medical Design Briefs Podcast” und abonniere ihn in der kostenlosen GetPodcast App.








